Clinical studies have demonstrated significant weight loss achieved by semaglutide in individuals without diabetes, making it a valuable potential treatment option for patients struggling with obesity
1 and are summarized in detail below
This dual action on satiety and gastric motility contributes substantially to their weight loss effects
MASLD (metabolic dysfunction-associated steatotic liver disease) is what most people know as "fatty liver." It means excess fat has built up in the liver, which over time can cause inflammation, scarring, and serious liver damage
Now at roughly two and a half years on a GLP-1 (shes been on a maintenance dose of Wegovy for the past several months), Long says the biggest game changer is the way its muted her constant food noise. Dr
By addressing root causesinsulin resistance, obesity, and inflammationGLP1s offer a multi-system benefit that aligns with modern chronic disease management goals